NH Stock Overview
NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States and internationally.
Price History & Performance
|Historical stock prices|
|Current Share Price||US$1.12|
|52 Week High||US$6.60|
|52 Week Low||US$1.06|
|1 Month Change||-28.66%|
|3 Month Change||-49.55%|
|1 Year Change||-53.72%|
|3 Year Change||31.78%|
|5 Year Change||-88.71%|
|Change since IPO||-93.98%|
Recent News & Updates
|NH||US Healthcare Services||US Market|
Return vs Industry: NH underperformed the US Healthcare Services industry which returned -9.1% over the past year.
Return vs Market: NH underperformed the US Market which returned 20% over the past year.
|NH Average Weekly Movement||8.9%|
|Healthcare Services Industry Average Movement||8.3%|
|Market Average Movement||6.0%|
|10% most volatile stocks in US Market||15.0%|
|10% least volatile stocks in US Market||2.3%|
Stable Share Price: NH is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 9% a week.
Volatility Over Time: NH's weekly volatility (9%) has been stable over the past year.
About the Company
NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States and internationally. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that centralizes clinical content and treatment cost data from Medicare reimbursements and treatment toxicity data; Eviti Connect, which utilizes the platform to offer pre-authorization automation that helps payers and providers navigate the complexities of cancer care; and Eviti Advisor product that allows physicians to access the Eviti platform’s comprehensive library of evidence-based treatment standards and protocols to inform treatment decisions. The company also provides NaviNet, a suite of SaaS-based solution enabling payers and providers to streamline communication and consolidate information; NaviNet Open, a payer-provider collaboration platform for communication between health plans and providers; NaviNet AllPayer that provides eligibility, benefit, and claim status information to provider offices for commercial and government plans and CMS for Medicare beneficiaries through the NaviNet portal; and OpenNMS is an open-source network monitoring solution for enterprise-grade networks.
NantHealth Fundamentals Summary
|NH fundamental statistics|
Is NH overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|NH income statement (TTM)|
|Cost of Revenue||US$23.08m|
Last Reported Earnings
Sep 30, 2021
Next Earnings Date
|Earnings per share (EPS)||-0.53|
|Net Profit Margin||-94.57%|
How did NH perform over the long term?See historical performance and comparison
Is NantHealth undervalued compared to its fair value and its price relative to the market?
In this section, we usually try to help investors determine whether NantHealth is trading at an attractive price based on the cash flow it is expected to produce in the future. But as NantHealth has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.
This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.
How is NantHealth forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: NH is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: NH is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: NH is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: NH's revenue (16.6% per year) is forecast to grow faster than the US market (10.1% per year).
High Growth Revenue: NH's revenue (16.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if NH's Return on Equity is forecast to be high in 3 years time
How has NantHealth performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: NH is currently unprofitable.
Growing Profit Margin: NH is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: NH is unprofitable, but has reduced losses over the past 5 years at a rate of 15.1% per year.
Accelerating Growth: Unable to compare NH's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NH is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (17%).
Return on Equity
High ROE: NH's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.
How is NantHealth's financial position?
Financial Position Analysis
Short Term Liabilities: NH has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: NH has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: NH has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: NH's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: NH has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: NH has sufficient cash runway for 1.3 years if free cash flow continues to grow at historical rates of 29% each year.
What is NantHealth current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate NH's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate NH's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if NH's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if NH's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of NH's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Patrick Soon-Shiong (68 yo)
Dr. Patrick Soon-Shiong, M.D., FRCS (C), FACS, MBBCh, MSc, FRCS (C), is an Owner and Executive Chairman of Los Angeles Times Communications, LLC. Dr. Soon-Shiong serves as a Director at Keyssa, Inc. He ser...
Experienced Management: NH's management team is considered experienced (2 years average tenure).
Experienced Board: NH's board of directors are considered experienced (5.5 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 3.8%.
NantHealth, Inc.'s employee growth, exchange listings and data sources
- Name: NantHealth, Inc.
- Ticker: NH
- Exchange: NasdaqGS
- Founded: 2010
- Industry: Health Care Technology
- Sector: Healthcare
- Market Cap: US$129.299m
- Shares outstanding: 115.45m
- Website: https://nanthealth.com
Number of Employees
- NantHealth, Inc.
- 9920 Jefferson Boulevard
- Culver City
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/12/01 00:10|
|End of Day Share Price||2021/11/30 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.